Chondros Dimitrios 4
4 · HALOZYME THERAPEUTICS INC · Filed Feb 22, 2019
Insider Transaction Report
Form 4
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-02-22−3,884→ 7,767 totalExercise: $0.00→ Common Stock (3,884 underlying) - Tax Payment
Common Stock
2019-02-22$16.81/sh−1,343$22,576→ 38,575 total - Exercise/Conversion
Common Stock
2019-02-22+3,884→ 39,918 total
Footnotes (2)
- [F1]The reported disposition of 1,343 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.